| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) | 9,545 | -25,593 | -29,830 | -32,097 |
| Add net loss (income) attributable to noncontrolling interest | -1 | 21 | 22 | -26 |
| Net income (loss) attributable to adaptive biotechnologies corporation | 9,546 | -25,614 | -29,852 | -32,071 |
| Earnings per share, basic | 0.06 | -0.17 | -0.2 | -0.22 |
| Earnings per share, diluted, total | 0.06 | -0.17 | -0.2 | -0.22 |
| Weighted average number of shares outstanding, basic, total | 152,432,307 | 152,082,284 | 149,195,028 | 147,516,398 |
| Weighted average number of shares outstanding, diluted, total | 163,162,107 | 152,082,284 | 149,195,028 | 147,516,398 |
Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (ADPT)